Hey everyone! ☕
I thought it be best to start doing a weekly newsletter letting you guys know what I'm looking at , what I'm doing , what has happened that I'm interested in and holding. Now honestly I Been debating about it for a while as I'm never the best to write stuff . LOL. I just thought it would help be transparent alongside the videos and be able to use this to answer people questions (That I can legally answer)
Today is a huge day on my radar. Rocket Lab (RKLB) dropped earnings and as a long-term investor myself, I’m dropping a full video breakdown at 2:00 PM over on the YouTube channel.
Here is my quick breakdown of Rocket Lab’s Q2 results, my updated investor thesis and where I stand on adding to my position following the report.
1. THE MAIN EVENT: Rocket Lab (RKLB) Earnings Breakdown & Post-Report Outlook
Rocket Lab delivered a record-breaking quarter on paper, but short-term market reactions show why looking past the headlines matters for long-term holders:
Record Revenue & Explosive Backlog: Q2 revenue surged 62% year-over-year to a record $234M (beating estimates), while gross margins outperformed guidance at 36.1%. Total backlog expanded to a massive $2.36 billion, driven by surging demand in Space Systems and suborbital HASTE contracts.
Neutron Timeline Realities: While flight hardware is still targeting delivery to the pad in Q4 2026, management acknowledged the window for an actual launch before year-end is narrowing. The market sold off on fears of a potential launch slip into early 2027, but as a long-term investor, I prioritize scaling seamless execution over a rushed initial launch window.
Capital Reserve & Acquisition Moves: With over $2B in liquidity post-ATM equity raise and major satellite/constellation acquisitions (like Mynaric, Motiv, and the planned Iridium deal), Rocket Lab is executing its vertical integration playbook aggressively while absorbing short-term capex burn.
2. STOCKS ON MY WATCHLIST THIS WEEK
RKLB (Primary Focus / Buying): My buy target range is $75.00 – $120.00. Sitting comfortably in my primary accumulation range—anything below $75 is an absolute auto-add for me as a long-term holder.
BROS (Watching Closely): Target buy price is ~$45.00. Recent earnings were solid, but investors were discouraged by management's Q3 same-shop sales growth guidance (5%–6%). The sell-off looks overdone, and if it touches $45, I’ll be significantly more interested.
CCL (Approaching Buy Zone): Target buy price is ~$27.00. Currently trailing down from the $29 mark over the last 5 days to $27.73. Approaching my target buy zone where risk/reward looks attractive.
3. TODAY ON THE CHANNEL (Dropping at 2:00 PM)
We are running a slide-by-slide deep dive into the presentation deck and financial metrics.
👉https://www.youtube.com/@WeeklyMouseInvestor (Out at 2:00 PM)
4. NEW TO INVESTING? START HERE
If you are looking to build a structured portfolio from scratch or refine your stock research framework, check out my complete step-by-step guide:
👉
⚠️ DISCLAIMER: The content in this post is for informational and educational purposes only and reflects my personal opinions as an investor. I am not a financial advisor. Stock market investing involves risk of loss. Always conduct your own thorough research or consult with a certified financial professional before making any investment decisions.
Thank you as always for supporting the channel! Keep investing step-by-step! ☕